Skip to main content
logo
Ascelia Pharma AB (publ) (STO:ACE)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.5340
-0.0040 (-0.74%)
Nov 4, 2026, 9:42 AM CET

Ascelia Pharma AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
714082811145031,005
Market Cap Growth
-82.46%45.35%146.68%-77.38%-49.95%-36.78%
Enterprise Value
3433721276324716
Last Close Price
0.543.212.923.3714.9429.85

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-80.38----
PB Ratio
0.804.103.561.532.783.27
P/TBV Ratio
2.199.6212.836.594.064.01

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.010.320.010.000.01
Net Debt / Equity Ratio
-0.42-0.49-0.63-0.28-0.82-0.84
Net Debt / EBITDA Ratio
0.630.660.730.191.011.89
Net Debt / FCF Ratio
0.560.680.790.161.192.23
Quick Ratio
4.014.291.311.984.1210.65
Current Ratio
4.114.351.352.304.2910.94
Return on Equity (ROE)
-65.52%-85.48%-104.43%-85.65%-53.70%-46.30%
Return on Assets (ROA)
-32.92%-36.65%-37.35%-45.59%-33.44%-29.27%
Return on Capital Employed (ROCE)
-66.10%-74.50%-86.30%-149.60%-81.60%-44.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-89.26%-18.70%-28.52%-96.07%-26.09%-12.53%
FCF Yield
-93.53%-17.73%-22.39%-111.45%-24.90%-11.60%
Buyback Yield / Dilution
-41.53%-110.07%-60.15%3.10%-5.58%-25.46%